Cash ReservesThe company reported cash, cash equivalents, and investments of approximately $624M with no debt.
Financial PerformanceITeos Therapeutics is leveraging its strong cash position to return as much value as possible to shareholders.
Investor SentimentInvestors reacted positively to the news of belrestotug’s termination, with the stock showing an increase, likely due to the announcement of a strategic review to maximize shareholder value.